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factors of the malnutrition development in CRF patients treated with CAPD.
Nutritional status was studied in 244 PD patients (97 women, 146 men; age
59.58716.55 years) being under CAPD during 1-104 (median 30) months.
Anthropometric (body mass index, dermato-fatty fold over 3-headed muscle,
Subjective Global Assessment SGA, normalized protein catabolic rate nPCR) and
biochemical indices (hemoglobin Hb, serum albumin SALB, serum pre-albumin
Spre-ALB, serum cholesterol SChol) were used for nutritional status estimation.
The overall mean body mass index was 28.18747.11. The mean level of
hemoglobin was 101.30723.81 g/L, Scr was 857.287336.17 umol/L, KT/V was
2.2570.73. The overall mean SALB was 30.6775.58 g/L, 74.2% patients on low
SALB (SALB o35 g/L). The mean level of Spre-ALB was 331.63791.43mg/L,
35.66% patients on low Spre-ALB (Spre-ALB o300mg/L). The mean level of PCR
was 0.9370.24 g/kg.d, 59.01% patients on low level PCR (PCR o1 g/kg.d). The
mean dermato-fatty fold over 3-headed muscle was 13.42 mm. 25% patients
had a SGA score of 1-4(malnutrition range). The prevalence of malnutrition was
18.03%. The main cause (44.6%) of death is infection in our study, and the
majority of these patients were complicated with different level of malnutrition.
In conclusion, the results indicate that malnutrition is quite common and plays
an important role in mortality in CAPD patients independent of dialysis efﬁcacy
and prevention or treatment of malnutrition by suitable means is necessary to
improve clinical outcomes in CAPD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.530207
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Protein-energy malnutrition is present in a large proportion of patients with
end stage renal disease and, is a strong risk factor for mortality in these patients.
This study was aimed to evaluate the effectiveness of 12-weeks nutrition
education during the hemodialysis session for the improvement of nutritional
status. From the June 2011 to the September 2011, patients who were on
regular hemodialysis in Pusan National University Hospital were enrolled in this
study. In education group, intensive nutrition education was performed by the
hemodialysis nurse, for ﬁfty to sixty minutes during the hemodialysis session,
once a week. Curriculum for renal nutrition includes regular taking of their
medication, intake of moderate amount of protein and sufﬁcient calories,
reduction of water, salt, potassium and phosphate intake. Otherwise, any
education program was not performed in patients of control group. Nutrition
status was assessed by the subjective global assessment (SGA),body mass index
(BMI), triceps skinfold thickness (TSF), arm muscle area(AMC) and laboratory
markers such as serum albumin, serum blood urea nitrogen(BUN) and
hemoglobin(Hb) level before and after the education. Effect of nutrition
education was analyzed using ANCOVA test. A total of 49 patients were enrolled
in this study and nutrition education was provided to 25 hemodialysis patients.
Their mean age was 57.20715.49 in education group and 55.13714.42 in
control groupand male was 56.0% in education group and 50.0% in control
group and, other baseline characteristics were not signiﬁcantly different
between two groups. After the 12-week education, signiﬁcant improvement
was found in SGA, serum albumin, BUN and Hb level. SGA score was improved
from 6.3670.99 to 6.7270.61 in education group, compared to control
group(6.3870.88 to 6.4270.88, p¼0.029 ). Improvement of serum albumin
level, BUN and Hb was as follows: serum albumin(4.2370.28 to 4.3070.25 in
education group, 4.2870.39 to 4.1370.34 in control group, p¼0.040), serum
Hb(10.4571.49 to 11.1371.74 in education group, 10.5171.12 to
10.0471.02 in control group, P¼0.004), serum BUN(66.52718.76 to
70.94717.26 in education group, 59.50713.61 to 58.68713.88 in control
group, p¼0.032). 12 week nutrition education during the hemodialysis session
by hemodialysis nurse was effective
http://dx.doi.org/10.1016/j.krcp.2012.04.531208
HIGH SALT INTAKE IN PREGNANCY ALTERS MATURATION OF
GLOMERULI IN THE RAT OFFSPRING
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GermanyThere is currently discussion on the optimal salt intake and uncertainty
whether both high and low salt intake is associated with adverse effects. One
aspect has so far not be considered, i.e. the potential impact of salt intake during
pregnancy on kidney function and blood pressure in the offspring. Faulty fetal
programming, amongst others by high or low salt intake, leads to alterations in
kidney morphology and albuminuria in the offspring. A low number of
glomeruli is known to cause high blood pressure later in life. It was the purpose
of the present study to clarify whether very high (or low) salt intakes in
pregnancy affect kidney development in the offspring. Sprague-Dawley rats
were fed normal (0.15%), medium (1.3%), or high (8.0%) salt diet during
pregnancy and weaning. The number of glomeruli (mature, immature, and
S-shape bodies) was assessed at 1 week postnatally. The expression of proteins
of interest was assessed (by western blotting) at 1 week postnatally and at
term. There was no difference between the groups with respect to litter size,
birth weight, and placenta size. At age 1 week the number of S-shaped bodies
was signiﬁcantly lower (4057308) and the number of mature glomeruli
(8187405) and layers of developing glomeruli (7.170.6) was signiﬁcantly
higher in the offspring of mothers on high-salt compared to the medium or low
salt groups (10447490, 4607304, and 5.970.9 respectively). As a net result
the total number of glomeruli was signiﬁcantly lower in the offspring of
mothers on high-salt (947671264) compared to the medium or low salt
groups (1117571920). At 1 week of age in the offspring of mothers on high
salt the glomeruli were bigger compared to lower salt intake. The expression of
Pax-2 (54723% vs. 100728%) and FGF-2 (72733% vs. 100730%) was
signiﬁcantly lower in the offspring of mothers on high-salt consistent with their
causative role. We conclude that high maternal salt intake during pregnancy
accelerates maturation of glomeruli in the offspring, but reduces the ﬁnal
number of glomeruli.
http://dx.doi.org/10.1016/j.krcp.2012.04.532209
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This review evaluated the effectiveness of pre-, pro- and synbiotics on
reducing a nephro-vascular uremic toxin, indoxyl sulphate (IS), involved in
cardiovascular disease in chronic kidney disease. A review of the literature
using Cochrane, PUBMED, EMBASE and CINAHL was conducted from 1951
to 2011 (inclusive). Studies were included if they reported change in IS (or
their precursors) as outcome measures in pre-, pro- or synbiotic
interventions with a duration of more than one day, were in English
language, in human adults with chronic kidney disease (Stage I to V
(dialysis)). From the 87 papers identiﬁed, ﬁve met the inclusion criteria
involving 87 patients, all of whom were receiving hemodialysis.
One study investigated prebiotics, three probiotics and one synbiotics.
The quality of the studies was limited (GRADE either low or very low).
Summary statistics were translated into means and standard errors,
assuming normal distribution.
There is limited but supportive evidence for the effectiveness of pre- and
probiotics on reducing IS in the chronic kidney disease population. Well-
designed fully-powered studies are needed in order to evaluate the
potential use of this treatment in the clinical setting.
http://dx.doi.org/10.1016/j.krcp.2012.04.533
